The administration of heme as an HO-1 inducer has been considered as a therapeutic approach and, as described above, pre-treatment with low doses of heme in different animal models of kidney disease has been associated with a decrease in inflammation, oxidative stress and tissue damage [315,316,317]. The gene discussed is HMOX1; the disease is kidney disorder.